Simple reversed-phase liquid chromatographic assay for simultaneous quantification of free mycophenolic acid and its glucuronide metabolite in human plasma

被引:12
作者
Yau, Wai-Ping
Vathsala, Anantharaman
Lou, Huei-Xin
Zhou, Shu Feng
Chan, Eli
机构
[1] Natl Univ Singapore, Dept Pharm, Singapore 117543, Singapore
[2] Singapore Gen Hosp, Dept Renal Med, Singapore 169608, Singapore
[3] Singapore Gen Hosp, Dept Pharm, Singapore 169608, Singapore
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2007年 / 846卷 / 1-2期
关键词
mycophenolic acid; mycophenolic acid glucuronide; reversed-phase HPLC; free drug; human plasma;
D O I
10.1016/j.jchromb.2006.07.062
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A reversed-phase HPLC-UV method, involving simple instrumental setup and mobile phase without ion-pairing reagent, was developed and validated for direct simultaneous quantification of free mycophenolic acid (MPA) and its major metabolite MPA-glucuronide (MPAG) in human plasma. Both free MPA and MPAG were isolated from plasma samples using ultrafiltration prior to analysis. Each chromatographic run was completed within 13 min. The optimized method showed good performance in terms of specificity, linearity (r(2) = 0.9999), sensitivity (limit of quantitation (LOQ): 0.005 mg/L for MPA; 1 mg/L for MPAG), and intra- and inter-day precision (R.S.D. < 7%). This assay was successfully applied to free MPA and MPAG measurements in clinical samples. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 24 条
[1]   Simultaneous determination of free mycophenolic acid and its glucuronide in serum of patients under mycophenolate mophetil therapy by ion-pair reversed-phase liquid chromatography with diode array UV detection [J].
Aresta, A ;
Palmisano, F ;
Zambonin, CG ;
Schena, P ;
Grandaliano, G .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 810 (02) :197-202
[2]   Quantification of free mycophenolic acid and its glucuronide metabolite in human plasma by liquid-chromatography using mass spectrometric and ultraviolet absorbance detection [J].
Atcheson, B ;
Taylor, PJ ;
Mudge, DW ;
Johnson, DW ;
Pillans, PI ;
Tett, SE .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2004, 799 (01) :157-163
[3]   Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant [J].
Atcheson, BA ;
Taylor, PJ ;
Mudge, DW ;
Johnson, DW ;
Hawley, CM ;
Campbell, SB ;
Isbel, NM ;
Pillans, PI ;
Tett, SE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (03) :271-280
[4]   Clinical pharmacokinetics of mycophenolate mofetil [J].
Bullingham, RES ;
Nicholls, AJ ;
Kanmm, BR .
CLINICAL PHARMACOKINETICS, 1998, 34 (06) :429-455
[5]  
Bullingham RES, 1996, TRANSPLANT P, V28, P925
[6]   Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patients [J].
Cattaneo, D ;
Gaspari, F ;
Ferrari, S ;
Stucchi, N ;
Del Priore, L ;
Perico, N ;
Gotti, E ;
Remuzzi, G .
CLINICAL TRANSPLANTATION, 2001, 15 (06) :402-409
[7]   Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus [J].
Jain, A ;
Venkataramanan, R ;
Hamad, IS ;
Zuckerman, S ;
Zhang, SM ;
Lever, J ;
Warty, VS ;
Fung, JJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (03) :268-276
[8]   Simple high-performance liquid chromatographic assay, with post-column derivatization, for simultaneous determination of mycophenolic acid and its glucuronide metabolite in human plasma and urine [J].
Jiao, Z ;
Zhong, Y ;
Shen, J ;
Yu, YQ .
CHROMATOGRAPHIA, 2005, 62 (7-8) :363-371
[9]  
Korecka M, 1999, CLIN CHEM, V45, P1047
[10]  
KORECKA M, 2001, THER DRUG MONIT, V23, P471